X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (200) 200
Publication (21) 21
Book Chapter (6) 6
Newspaper Article (6) 6
Book Review (5) 5
Book / eBook (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (97) 97
middle aged (70) 70
female (67) 67
male (67) 67
adult (59) 59
oncology (51) 51
aged (49) 49
antineoplastic combined chemotherapy protocols - therapeutic use (40) 40
hematology (30) 30
index medicus (29) 29
adolescent (28) 28
treatment outcome (21) 21
chemotherapy (19) 19
disease-free survival (17) 17
prognosis (17) 17
cancer (16) 16
doxorubicin - administration & dosage (16) 16
non-hodgkins-lymphoma (16) 16
recurrence (16) 16
hodgkin disease - therapy (15) 15
neoplasm staging (15) 15
cyclophosphamide - administration & dosage (14) 14
disease (14) 14
lymphomas (14) 14
time factors (14) 14
young adult (14) 14
aged, 80 and over (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
combined modality therapy (13) 13
hodgkin's disease (13) 13
retrospective studies (13) 13
vincristine - administration & dosage (13) 13
antineoplastic agents - therapeutic use (12) 12
hodgkin disease - drug therapy (12) 12
prednisone - administration & dosage (12) 12
survival rate (12) 12
therapy (12) 12
article (11) 11
lymphoma, large b-cell, diffuse - drug therapy (11) 11
medicine & public health (11) 11
remission induction (11) 11
rituximab (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
care and treatment (10) 10
drug therapy, combination (10) 10
hodgkin disease - pathology (10) 10
lymphoma, non-hodgkin - therapy (10) 10
etoposide - administration & dosage (9) 9
lymphoma - drug therapy (9) 9
lymphoma, non-hodgkin - drug therapy (9) 9
survival analysis (9) 9
trial (9) 9
antineoplastic agents - administration & dosage (8) 8
drug administration schedule (8) 8
follicular lymphoma (8) 8
hodgkin disease - mortality (8) 8
lymphoma (8) 8
lymphoma, non-hodgkin - pathology (8) 8
prospective studies (8) 8
radiotherapy (8) 8
abridged index medicus (7) 7
antibodies, monoclonal, murine-derived (7) 7
bleomycin - administration & dosage (7) 7
combination chemotherapy (7) 7
dacarbazine - administration & dosage (7) 7
expression (7) 7
ifosfamide - administration & dosage (7) 7
lymphoma, b-cell - drug therapy (7) 7
positron-emission tomography (7) 7
positron-emission-tomography (7) 7
transplantation, autologous (7) 7
vinblastine - administration & dosage (7) 7
antibodies, monoclonal - administration & dosage (6) 6
b-cell lymphoma (6) 6
bone marrow transplantation (6) 6
bone-marrow transplantation (6) 6
bortezomib (6) 6
child (6) 6
etoposide (6) 6
follow-up studies (6) 6
hodgkin disease - radiotherapy (6) 6
neoplasms (6) 6
prednisone - therapeutic use (6) 6
risk factors (6) 6
salvage therapy (6) 6
survival (6) 6
transplantation (6) 6
vincristine - therapeutic use (6) 6
chemotherapy, adjuvant (5) 5
dose-response relationship, drug (5) 5
fluorodeoxyglucose f18 (5) 5
follow-up (5) 5
health aspects (5) 5
hemic and lymphatic diseases (5) 5
hodgkin disease - diagnostic imaging (5) 5
hodgkin lymphoma (5) 5
lymphoma - therapy (5) 5
lymphoma, large b-cell, diffuse - therapy (5) 5
non-hodgkin's lymphomas (5) 5
pathology (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1986, 2nd ed. --, A Little, Brown spiral manual, ISBN 0316714259, ix, 358 p. --
Book
1986, Current treatment of cancer., ISBN 9783540162933, xv, 111
Book
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 284 - 292
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2010, Volume 28, Issue 11, pp. 1896 - 1903
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1803 - 1803
Abstract Background Mantle cell lymphoma (MCL) is a biologically heterogeneous disease with a variable clinical course, ranging from indolent to highly... 
Journal Article
Blood, ISSN 0006-4971, 11/2017, Volume 130, Issue 20, pp. 2196 - 2203
Journal Article
Blood, ISSN 0006-4971, 04/2018, Volume 131, Issue 16, pp. 1805 - 1808
In the postrituximab era, approximately half of the patients with relapsed or refractory (rel/ref) diffuse large B-cell lymphoma (DLBCL) fail to achieve a... 
B-CELL LYMPHOMA | CARBOPLATIN | ETOPOSIDE | THERAPY | PLUS RITUXIMAB | HEMATOLOGY | IFOSFAMIDE | CHEMOTHERAPY | TRANSPLANTATION | Clinical Trials and Observations | Brief Report
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1778 - 1778
Abstract Introduction: The combination of bendamustine (B) and rituximab (R) is an effective and relatively well tolerated treatment for B-cell malignancies.... 
Journal Article
Journal Article
Journal of Palliative Medicine, ISSN 1096-6218, 07/2011, Volume 14, Issue 7, pp. 835 - 839
Journal Article
Blood, ISSN 0006-4971, 09/2016, Volume 128, Issue 11, pp. 1458 - 1464
Journal Article